COLLERETTO GIACOSA (Turin, Italy). 25th January 2010. Eporgen Venture SpA (Eporgen) has announced today the organization on Thursday, January 28th, 2010 of “Nurturing the Winners”, a private, by invitation-only event to present the 11 biotech start-up companies in its portfolio.
“This event is an opportunity to hear about the companies in Eporgen’s portfolio, meet the scientists that created and advanced these start-ups to their current status, as well as to explore financing and partnering opportunities”, said Konstantinos Efthymiopoulos, President of Eporgen.
Leading scientists, business development executives from international pharma and biotech companies, venture capital firms and institutional and private investors have been invited to attend the event, which will take place in the Bioindustry Park S. Fumero in Colleretto Giacosa (Turin, Italy).
About Eporgen Venture SpA
Eporgen Venture is the first Italian company, entirely funded by private, non-institutional investors, which is dedicated to seed capital investments in the area of life sciences. Eporgen commenced operations in 2005 and is based in the Bioindustry Park S. Fumero in Colleretto Giacosa (Turin, Italy).
Eporgen’s mission is to identify and select innovative projects in the area of life sciences, in which it invests in order to create a balanced portfolio of small start-up companies that are supported in their management and controlled by Eporgen. These start-up companies are built around intellectual property that is being developed up to a proof-of-concept and subsequently licensed out to suitable partners. Eporgen’s current portfolio is constituted by 11 companies, which develop innovative products in areas such as oncology, cardiovascular diseases, anti-infectives, auto-immune diseases and diagnostics.
For more information about Eporgen, please visit our web site (http://www.eporgen.com) or contact us by e-mail (info@eporgen.com).
